Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer

PURPOSE: With the emergence of various novel therapies including new generation taxane and androgen-targeted therapies, the optimal sequence of systemic treatment in metastatic castration-resistant prostate cancer (mCRPC) patients remains to be defined. Our aim is to investigate the impact of durati...

Descripción completa

Detalles Bibliográficos
Autores principales: Poon, Darren M.C., Ng, Joyce, Chan, Kuen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494213/
https://www.ncbi.nlm.nih.gov/pubmed/26157768
http://dx.doi.org/10.1016/j.prnil.2015.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494213/
https://www.ncbi.nlm.nih.gov/pubmed/26157768
http://dx.doi.org/10.1016/j.prnil.2015.03.002

Ejemplares similares